Zolgensma, a curative gene therapy for spinal muscular atrophy (SMA) hit the market in 2019. Now it costs $2M, making it one of the cheaper gene therapies currently available. This deep dive by ProPublica sheds light on how value and pricing are determined in the age of modern medicine, and by whom.

Cole Schmidtknecht, 22, died of an asthma attack after his preventative asthma inhaler went up in price from $66.86 to $539.19 after his PBM removed coverage of the inhaler. He never received notice that the PBM controlling his health benefits had removed the inhaler from their approved list of therapies.

A follow-up to the first report released by the FTC, this report expands the scope to cover additional drugs. The report finds that Caremark, Optum Rx, and Express Scripts hiked prices of many specialty generic drugs distributed at their own pharmacies.

A consortium of Philadelphia pharmacists sued discount drug card aggregator GoodRx and the nation’s largest pharmacy benefit managers, alleging the companies employed anticompetitive practices, including price fixing, to restrain competition.

A group of legislators is calling on the Department of Justice to dig into whether pharmacy benefit managers played a role in the opioid epidemic.

The cost of prescription drugs in the U.S. isn’t like the tabs for other products. The price for a single medicine can range by thousands of dollars depending on the drug plan.